Rigel Pharmaceuticals, Inc. (RIGL)
USD 18.8
(3.5%)
USD 18.8
(3.5%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 60.57 Million USD | 45.79% |
| 2022 | 41.55 Million USD | 35.95% |
| 2021 | 30.56 Million USD | -21.8% |
| 2020 | 39.08 Million USD | 7.64% |
| 2019 | 36.31 Million USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 284 Thousand USD | -91.79% |
| 2016 | 3.46 Million USD | -46.48% |
| 2015 | 6.46 Million USD | -30.25% |
| 2014 | 9.26 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 800 Thousand USD | -58.85% |
| 2009 | 1.94 Million USD | -42.69% |
| 2008 | 3.39 Million USD | 91.21% |
| 2007 | 1.77 Million USD | -24.54% |
| 2006 | 2.35 Million USD | 6.77% |
| 2005 | 2.2 Million USD | 4.76% |
| 2004 | 2.1 Million USD | -39.86% |
| 2003 | 3.49 Million USD | -38.69% |
| 2002 | 5.7 Million USD | -23.1% |
| 2001 | 7.41 Million USD | -18.64% |
| 2000 | 9.11 Million USD | 19.06% |
| 1999 | 7.65 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 60.33 Million USD | -0.28% |
| 2024 Q1 | 60.49 Million USD | -0.13% |
| 2023 Q4 | 60.57 Million USD | -0.36% |
| 2023 Q2 | 60.66 Million USD | -0.11% |
| 2023 Q3 | 60.79 Million USD | 0.21% |
| 2023 Q1 | 60.73 Million USD | 46.16% |
| 2023 FY | 60.57 Million USD | 45.79% |
| 2022 Q4 | 41.55 Million USD | -2.87% |
| 2022 FY | 41.55 Million USD | 35.95% |
| 2022 Q3 | 42.78 Million USD | 20.02% |
| 2022 Q2 | 35.64 Million USD | -6.55% |
| 2022 Q1 | 38.14 Million USD | 24.79% |
| 2021 FY | 30.56 Million USD | -21.8% |
| 2021 Q1 | 37.05 Million USD | -5.19% |
| 2021 Q2 | 34.93 Million USD | -5.73% |
| 2021 Q3 | 32.77 Million USD | -6.18% |
| 2021 Q4 | 30.56 Million USD | -6.74% |
| 2020 Q4 | 39.08 Million USD | -4.9% |
| 2020 Q1 | 34.91 Million USD | -3.85% |
| 2020 Q3 | 41.09 Million USD | -4.68% |
| 2020 Q2 | 43.11 Million USD | 23.5% |
| 2020 FY | 39.08 Million USD | 7.64% |
| 2019 Q1 | 31.7 Million USD | 0.0% |
| 2019 FY | 36.31 Million USD | 0.0% |
| 2019 Q3 | 38.22 Million USD | 27.04% |
| 2019 Q4 | 36.31 Million USD | -5.0% |
| 2019 Q2 | 30.08 Million USD | -5.1% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | -100.0% |
| 2018 Q1 | - USD | -100.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q3 | 1.24 Million USD | -43.17% |
| 2017 FY | 284 Thousand USD | -91.79% |
| 2017 Q2 | 2.19 Million USD | -29.77% |
| 2017 Q1 | 3.12 Million USD | -2.95% |
| 2017 Q4 | 284 Thousand USD | -77.24% |
| 2016 FY | 3.46 Million USD | -46.48% |
| 2016 Q1 | 5.73 Million USD | 90.78% |
| 2016 Q3 | 4.23 Million USD | -15.19% |
| 2016 Q4 | 3.22 Million USD | -23.85% |
| 2016 Q2 | 4.98 Million USD | -12.98% |
| 2015 Q3 | 7.18 Million USD | -8.96% |
| 2015 Q4 | 3 Million USD | -58.17% |
| 2015 FY | 6.46 Million USD | -30.25% |
| 2015 Q1 | 8.58 Million USD | -7.37% |
| 2015 Q2 | 7.89 Million USD | -8.09% |
| 2014 FY | 9.26 Million USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 9.26 Million USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q3 | 134 Thousand USD | -57.46% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q2 | 315 Thousand USD | -42.62% |
| 2011 Q1 | 549 Thousand USD | -31.38% |
| 2010 Q1 | 1.62 Million USD | -16.51% |
| 2010 FY | 800 Thousand USD | -58.85% |
| 2010 Q4 | 800 Thousand USD | -24.88% |
| 2010 Q3 | 1.06 Million USD | -20.16% |
| 2010 Q2 | 1.33 Million USD | -17.81% |
| 2009 Q1 | 2.95 Million USD | -12.85% |
| 2009 Q4 | 1.94 Million USD | -14.32% |
| 2009 FY | 1.94 Million USD | -42.69% |
| 2009 Q3 | 2.26 Million USD | -12.66% |
| 2009 Q2 | 2.59 Million USD | -12.11% |
| 2008 Q2 | 2 Million USD | 19.8% |
| 2008 Q3 | 2.23 Million USD | 11.2% |
| 2008 Q4 | 3.39 Million USD | 51.84% |
| 2008 Q1 | 1.67 Million USD | -5.47% |
| 2008 FY | 3.39 Million USD | 91.21% |
| 2007 Q4 | 1.77 Million USD | -3.43% |
| 2007 FY | 1.77 Million USD | -24.54% |
| 2007 Q2 | 2.19 Million USD | -5.14% |
| 2007 Q1 | 2.31 Million USD | -1.49% |
| 2007 Q3 | 1.83 Million USD | -16.39% |
| 2006 FY | 2.35 Million USD | 6.77% |
| 2006 Q3 | 2.57 Million USD | -7.87% |
| 2006 Q2 | 2.79 Million USD | 1.01% |
| 2006 Q1 | 2.76 Million USD | 25.7% |
| 2006 Q4 | 2.35 Million USD | -8.73% |
| 2005 FY | 2.2 Million USD | 4.76% |
| 2005 Q4 | 2.2 Million USD | 9.99% |
| 2005 Q3 | 2 Million USD | -11.73% |
| 2005 Q2 | 2.26 Million USD | -14.03% |
| 2005 Q1 | 2.63 Million USD | 25.5% |
| 2004 FY | 2.1 Million USD | -39.86% |
| 2004 Q3 | 2.2 Million USD | -8.01% |
| 2004 Q4 | 2.1 Million USD | -4.71% |
| 2004 Q1 | 2.88 Million USD | -17.42% |
| 2004 Q2 | 2.39 Million USD | -16.91% |
| 2003 Q2 | 4.66 Million USD | -5.82% |
| 2003 Q3 | 4.02 Million USD | -13.66% |
| 2003 Q4 | 3.49 Million USD | -13.17% |
| 2003 Q1 | 4.95 Million USD | -13.17% |
| 2003 FY | 3.49 Million USD | -38.69% |
| 2002 Q2 | 7.16 Million USD | 1.77% |
| 2002 Q4 | 5.7 Million USD | -14.81% |
| 2002 FY | 5.7 Million USD | -23.1% |
| 2002 Q1 | 7.04 Million USD | -4.99% |
| 2002 Q3 | 6.69 Million USD | -6.65% |
| 2001 Q4 | 7.41 Million USD | -7.22% |
| 2001 Q3 | 7.99 Million USD | -8.86% |
| 2001 FY | 7.41 Million USD | -18.64% |
| 2001 Q1 | 8.39 Million USD | -7.85% |
| 2001 Q2 | 8.76 Million USD | 4.41% |
| 2000 Q4 | 9.11 Million USD | 0.0% |
| 2000 FY | 9.11 Million USD | 19.06% |
| 1999 FY | 7.65 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -1010.522% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -6158.161% |
| Vaxxinity, Inc. | 15.16 Million USD | -299.387% |
| IO Biotech, Inc. | 2.49 Million USD | -2328.99% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -888.238% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -185.225% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -79.069% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | 56.427% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -6586.424% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -3605.138% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -319.406% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -59879.208% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 73.596% |
| Agenus Inc. | 350.24 Million USD | 82.704% |
| AlloVir, Inc. | 27.42 Million USD | -120.857% |
| CRISPR Therapeutics AG | 238.63 Million USD | 74.614% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 73.568% |
| NextCure, Inc. | 6.6 Million USD | -817.169% |
| Opthea Limited | 200.62 Million USD | 69.805% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -70.38% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -762.457% |
| Senti Biosciences, Inc. | 37.66 Million USD | -60.832% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | 41.853% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -20045.055% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 97.742% |
| BioLineRx Ltd. | 11.59 Million USD | -422.638% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -3395.615% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -366.854% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -875.822% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -146.838% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -33.111% |
| AbCellera Biologics Inc. | 77.38 Million USD | 21.712% |
| ADMA Biologics, Inc. | 141.41 Million USD | 57.163% |
| Aptorum Group Limited | 3.36 Million USD | -1701.661% |
| AnaptysBio, Inc. | 17.81 Million USD | -240.064% |
| Ardelyx, Inc. | 55.98 Million USD | -8.212% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | 47.401% |
| Bicycle Therapeutics plc | 44.95 Million USD | -34.752% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | 40.248% |
| C4 Therapeutics, Inc. | 70.97 Million USD | 14.649% |
| Clearside Biomedical, Inc. | 43 Million USD | -40.878% |
| Chimerix, Inc. | 2.14 Million USD | -2725.513% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -190.071% |
| Dyadic International, Inc. | 136.92 Thousand USD | -44141.176% |
| Elevation Oncology, Inc. | 30.13 Million USD | -101.012% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -75314.55% |
| Fortress Biotech, Inc. | 88.59 Million USD | 31.62% |
| Fate Therapeutics, Inc. | 103.53 Million USD | 41.49% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -7393.673% |
| Fortress Biotech, Inc. | 88.59 Million USD | 31.62% |
| ChromaDex Corporation | 3.27 Million USD | -1748.612% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -109714.194% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -112.253% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -120.407% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -2009.297% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 71.172% |
| Incyte Corporation | 38.28 Million USD | -58.223% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -100.531% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -38241.139% |
| Jaguar Health, Inc. | 35.86 Million USD | -68.932% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 98.955% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -882.628% |
| ContextLogic Inc. | 6 Million USD | -909.65% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -25736.457% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | 48.308% |
| MiMedx Group, Inc. | 48.09 Million USD | -25.946% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | 45.107% |
| Structure Therapeutics Inc. | 5.45 Million USD | -1010.93% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -823.601% |
| Onconetix, Inc. | 9.88 Million USD | -512.79% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -18950.0% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -691.117% |
| PDS Biotechnology Corporation | 23.85 Million USD | -153.983% |
| Precigen, Inc. | 7.09 Million USD | -753.586% |
| Pharming Group N.V. | 171.54 Million USD | 64.686% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| PureTech Health plc | 25.51 Million USD | -137.453% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -777.194% |
| Royalty Pharma plc | 6.13 Billion USD | 99.013% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -114.371% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -58.983% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -3564.791% |
| Acelyrin, Inc. | 1.19 Million USD | -4973.618% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -20815.058% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -183.995% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -13344.94% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | 2.41% |
| TG Therapeutics, Inc. | 110.79 Million USD | 45.323% |
| Alkermes plc | 290.73 Million USD | 79.163% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | 11.214% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -10621.947% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -3490.931% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -2757.5% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -88.614% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -514.89% |
| Geron Corporation | 85.89 Million USD | 29.476% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -259.947% |
| Summit Therapeutics Inc. | 106.09 Million USD | 42.903% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -786.306% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -9639.342% |
| Innoviva, Inc. | 449.07 Million USD | 86.51% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -12653.474% |
| Vaxcyte, Inc. | 29.22 Million USD | -107.292% |
| Molecular Templates, Inc. | 12.23 Million USD | -395.331% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -28207.944% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | 54.961% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -137.044% |
| Novavax, Inc. | 280.63 Million USD | 78.414% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -211.54% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -1603.092% |
| Precision BioSciences, Inc. | 31.26 Million USD | -93.741% |
| GT Biopharma, Inc. | 58 Thousand USD | -104346.552% |
| ImmuCell Corporation | 11.96 Million USD | -406.12% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 118.92 Million USD | 49.06% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -141.91% |
| Aptose Biosciences Inc. | 1 Million USD | -5899.073% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -699749.815% |
| Soligenix, Inc. | 3.49 Million USD | -1633.522% |
| Century Therapeutics, Inc. | 48.17 Million USD | -25.758% |
| Kura Oncology, Inc. | 17.2 Million USD | -252.203% |
| TScan Therapeutics, Inc. | 92.43 Million USD | 34.462% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -2717.628% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -333.512% |
| Autolus Therapeutics plc | 52.96 Million USD | -14.371% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -1007.68% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -44.777% |
| GRI Bio, Inc. | 14 Thousand USD | -432607.143% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -387.597% |
| IGM Biosciences, Inc. | 40.5 Million USD | -49.556% |
| INmune Bio, Inc. | 10.43 Million USD | -480.425% |
| Heron Therapeutics, Inc. | 179.62 Million USD | 66.275% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -925.536% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -74066.259% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -7226.533% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -17.004% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -3.943% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -4.678% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 87.401% |
| Verastem, Inc. | 41.55 Million USD | -45.773% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -1021.833% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -432.703% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -517.334% |
| Histogen Inc. | 4.62 Million USD | -1210.666% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -1692.809% |
| Organovo Holdings, Inc. | 1.39 Million USD | -4245.696% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -31.689% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -1066.327% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -283642.389% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | 28.383% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -28882.394% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -100.486% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -37221.414% |
| Apollomics, Inc. | 4.66 Million USD | -1199.7% |
| Amarin Corporation plc | 8.73 Million USD | -593.362% |
| Turnstone Biologics Corp. | 3.21 Million USD | -1784.848% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | 28.456% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -24425.911% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | 37.936% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 68.107% |
| Better Therapeutics, Inc. | 14.88 Million USD | -307.117% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -97.88% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | 45.389% |
| NLS Pharmaceutics AG | 1.63 Million USD | -3607.982% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | 42.182% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -2074.408% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -123859.484% |
| Avid Bioservices, Inc. | 207.83 Million USD | 70.852% |
| Insmed Incorporated | 1.2 Billion USD | 94.968% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -802.682% |
| OmniAb, Inc. | 25.56 Million USD | -136.998% |
| Alector, Inc. | 38.91 Million USD | -55.658% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 71.684% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -299.835% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 87.338% |
| Aura Biosciences, Inc. | 19.55 Million USD | -209.756% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | 4.097% |
| Immunic, Inc. | 1.33 Million USD | -4441.154% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -90.908% |
| Veracyte, Inc. | 12.63 Million USD | -379.644% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 90.606% |
| FibroGen, Inc. | 170.45 Million USD | 64.46% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -567.096% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -29608.549% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -163627.027% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -1329.762% |
| Galecto, Inc. | 249 Thousand USD | -24228.916% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -3536.194% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 96.39% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -727.921% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -1022.457% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -2074.408% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -125.36% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -34.402% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -4169.133% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -33.918% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -40.33% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -25.607% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 92.862% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -5796.352% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -452.98% |
| NexImmune, Inc. | 68.8 Thousand USD | -87939.355% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -426693.011% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 97.759% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -15353.748% |
| Ainos, Inc. | 5.96 Million USD | -915.82% |
| Pluri Inc. | 29.61 Million USD | -104.576% |
| Prothena Corporation plc | 11.83 Million USD | -411.863% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -140.059% |
| Celularity Inc. | 65.41 Million USD | 7.396% |
| Rallybio Corporation | 392 Thousand USD | -15353.827% |
| Cue Biopharma, Inc. | 14.69 Million USD | -312.242% |
| MeiraGTx Holdings plc | 89.26 Million USD | 32.135% |
| Omeros Corporation | 338.28 Million USD | 82.092% |
| Humacyte, Inc. | 58.1 Million USD | -4.256% |
| Immunocore Holdings plc | 84.03 Million USD | 27.91% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -3169.239% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -1142.137% |
| Blueprint Medicines Corporation | 774.12 Million USD | 92.174% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -1107.234% |
| Scholar Rock Holding Corporation | 61.81 Million USD | 2.004% |
| Sana Biotechnology, Inc. | 104.09 Million USD | 41.805% |
| Pulmatrix, Inc. | 8.75 Million USD | -591.857% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -775.799% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -337.394% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | 47.481% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -92.022% |
| Cytokinetics, Incorporated | 755.77 Million USD | 91.984% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -352.623% |
| Nutriband Inc. | 241.28 Thousand USD | -25006.824% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -1008.085% |
| Vor Biopharma Inc. | 35.66 Million USD | -69.879% |
| Roivant Sciences Ltd. | 499.74 Million USD | 87.878% |
| Evogene Ltd. | 1.13 Million USD | -5223.286% |
| ProKidney Corp. | 4.41 Million USD | -1272.74% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -4841.191% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 96.518% |
| CorMedix Inc. | 667.63 Thousand USD | -8973.711% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -55.65% |
| Galectin Therapeutics Inc. | 71.8 Million USD | 15.636% |
| Atai Life Sciences N.V. | 16.47 Million USD | -267.68% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -2371.607% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -8874.667% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -32.347% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -93098.462% |
| MediciNova, Inc. | 215.92 Thousand USD | -27955.445% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -2328.016% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -4703.938% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | 67.496% |
| Biomea Fusion, Inc. | 10.29 Million USD | -488.374% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 85.404% |
| Mereo BioPharma Group plc | 5.95 Million USD | -917.792% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -1587.437% |
| Absci Corporation | 15.95 Million USD | -279.639% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -561.271% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -312.917% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -120.97% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -394.2% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -384.399% |
| Allakos Inc. | 41.46 Million USD | -46.097% |
| Imunon, Inc. | 1.62 Million USD | -3628.595% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -459.828% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -40018.543% |
| BioAtla, Inc. | 2.46 Million USD | -2362.561% |
| NLS Pharmaceutics AG | 1.63 Million USD | -3607.982% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -53509.735% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | 36.314% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -992.301% |
| XOMA Corporation | 124.45 Million USD | 51.323% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -219.965% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -40.336% |
| aTyr Pharma, Inc. | 15.09 Million USD | -301.318% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -443.895% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -132.611% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -187.814% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -17257.88% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -18454.456% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -3612.574% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 95.959% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -36845.849% |
| UroGen Pharma Ltd. | 100.21 Million USD | 39.55% |
| Sutro Biopharma, Inc. | 182.74 Million USD | 66.851% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -17391.093% |
| Orgenesis Inc. | 22.62 Million USD | -167.8% |
| Entera Bio Ltd. | 390 Thousand USD | -15433.077% |
| GH Research PLC | 343 Thousand USD | -17561.516% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -19761.967% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -6126.002% |
| Xencor, Inc. | 83.43 Million USD | 27.393% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -34983.076% |
| Replimune Group, Inc. | 75.86 Million USD | 20.153% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -4848.351% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -544.183% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -36845.849% |
| Portage Biotech Inc. | 47 Thousand USD | -128791.489% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -4703.938% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -2406.372% |
| OncoCyte Corporation | 2.86 Million USD | -2011.502% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -4562.735% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -40137.39% |
| Purple Biotech Ltd. | 351 Thousand USD | -17158.974% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -1817.664% |
| scPharmaceuticals Inc. | 40.26 Million USD | -50.436% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -18.335% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -42561.268% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -1058.077% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -126.565% |
| Curis, Inc. | 2.79 Million USD | -2068.182% |
| Daré Bioscience, Inc. | 5.31 Million USD | -1039.1% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -2735.499% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -262.076% |
| BeiGene, Ltd. | 930.18 Million USD | 93.487% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -289.764% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | 31.116% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -5209.29% |
| Erasca, Inc. | 55.85 Million USD | -8.45% |
| bluebird bio, Inc. | 330.32 Million USD | 81.661% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 94.657% |
| DBV Technologies S.A. | 14.38 Million USD | -321.243% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -2321.223% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -1204.457% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 85.034% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -31.582% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -1214.363% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -2283.124% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -221.323% |
| MacroGenics, Inc. | 33.97 Million USD | -78.326% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -189.519% |
| Prime Medicine, Inc. | 13.63 Million USD | -344.356% |
| Aditxt, Inc. | 18.21 Million USD | -232.523% |
| Adagene Inc. | 22.3 Million USD | -171.571% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -295.864% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 90.085% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -198.522% |
| SciSparc Ltd. | 76 Thousand USD | -79609.211% |
| Vericel Corporation | 88.14 Million USD | 31.272% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | 26.138% |
| Generation Bio Co. | 97.89 Million USD | 38.118% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -18313.07% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -139.462% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 70.581% |
| Invivyd, Inc. | 2.16 Million USD | -2698.106% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -13.304% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -1719072.581% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -992.892% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -96057.143% |
| 2seventy bio, Inc. | 256.67 Million USD | 76.398% |
| Clene Inc. | 32.16 Million USD | -88.362% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -979.425% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -2659.863% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -19.551% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -12487.975% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | 68.643% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -101.085% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -252.265% |
| Vir Biotechnology, Inc. | 124.54 Million USD | 51.358% |
| Evaxion Biotech A/S | 10.86 Million USD | -457.321% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | 27.354% |
| Verve Therapeutics, Inc. | 74.9 Million USD | 19.128% |
| Trevena, Inc. | 35.23 Million USD | -71.938% |
| Surrozen, Inc. | 3.37 Million USD | -1692.809% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -832.558% |
| Cingulate Inc. | 3.13 Million USD | -1832.283% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -147653.659% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -124.45% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -11993.958% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -9946.269% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -5.898% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -12927.742% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -114.272% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -199.614% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -3795.756% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -4707.857% |
| Statera Biopharma, Inc. | 16.26 Million USD | -272.539% |
| ImmunityBio, Inc. | 883.67 Million USD | 93.145% |
| Korro Bio, Inc. | 33.2 Million USD | -82.428% |
| Kineta, Inc. | 1.31 Million USD | -4499.772% |
| BioVie Inc. | 6.11 Million USD | -891.238% |
| Codexis, Inc. | 22.36 Million USD | -170.877% |
| Celularity Inc. | 65.41 Million USD | 7.396% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -17.111% |
| Celcuity Inc. | 37.44 Million USD | -61.776% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -26908.025% |
| Cibus, Inc. | 24.62 Million USD | -146.046% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -15716.971% |
| IN8bio, Inc. | 4.89 Million USD | -1138.075% |
| Kodiak Sciences Inc. | 181.63 Million USD | 66.647% |
| Annexon, Inc. | 31.35 Million USD | -93.204% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | 19.267% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -2486.635% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -1452.114% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 95.832% |
| Eyenovia, Inc. | 16.1 Million USD | -276.086% |
| Puma Biotechnology, Inc. | 111.49 Million USD | 45.664% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -6050.152% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -428.751% |
| Arcellx, Inc. | 97.62 Million USD | 37.947% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -2718.939% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -128.488% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -1852.901% |
| Moolec Science SA | 2.64 Million USD | -2190.071% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -112.655% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -859.591% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -2422.023% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -52461.299% |
| Humacyte, Inc. | 58.1 Million USD | -4.256% |
| 89bio, Inc. | 27.1 Million USD | -123.473% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -355.961% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -2304.883% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -4427.578% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | 42.884% |
| Notable Labs, Ltd. | 2.04 Million USD | -2856.515% |
| Liquidia Corporation | 3.5 Million USD | -1629.346% |
| Mustang Bio, Inc. | 2.49 Million USD | -2325.1% |
| Immunovant, Inc. | 138 Thousand USD | -43797.826% |
| Quantum-Si incorporated | 15.3 Million USD | -295.864% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -594.634% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -15044.75% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -12.793% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -74066.259% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -455.618% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -28680.126% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -29741.872% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -193.205% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -14932.01% |
| PepGen Inc. | 20.1 Million USD | -201.328% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -10453.833% |
| United Therapeutics Corporation | 700 Million USD | 91.346% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -130.645% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -1257.373% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -6737.359% |
| XOMA Corporation | 124.45 Million USD | 51.323% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -22009.124% |
| Bionomics Limited | 239.61 Million USD | 74.719% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -2878.32% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -356.305% |
| uniQure N.V. | 138.4 Million USD | 56.232% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | 29.084% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -5770.058% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -6050.152% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -567.096% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -3367.602% |
| Altimmune, Inc. | 671 Thousand USD | -8928.167% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 86.389% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -356.305% |
| Compugen Ltd. | 1.35 Million USD | -4384.012% |
| Peak Bio, Inc. | 10.72 Million USD | -465.007% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -41.652% |
| Benitec Biopharma Inc. | 284 Thousand USD | -21230.634% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | 28.356% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -204.096% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -414.297% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | 33.763% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -204.096% |
| Instil Bio, Inc. | 86.05 Million USD | 29.604% |
| argenx SE | 20 Million USD | -202.895% |
| Immunome, Inc. | 1.65 Million USD | -3571.455% |
| Verona Pharma plc | 51.32 Million USD | -18.021% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -519.544% |
| Shattuck Labs, Inc. | 4.2 Million USD | -1341.671% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -16634.53% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -1348.912% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -10255.385% |
| Moolec Science SA | 2.64 Million USD | -2190.071% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 3.05 Million USD | -1886.197% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -23021.756% |
| NeurAxis, Inc. | 224.26 Thousand USD | -26912.842% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -325.773% |
| Lumos Pharma, Inc. | 6.58 Million USD | -819.954% |
| Achilles Therapeutics plc | 4.61 Million USD | -1212.654% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -519.544% |
| 180 Life Sciences Corp. | 1.32 Million USD | -4489.078% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -254.675% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -3795.756% |
| Nutriband Inc. | 241.28 Thousand USD | -25006.824% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -493.156% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -7234.019% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 83.79% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -101.266% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -1538.215% |
| Palisade Bio, Inc. | 369 Thousand USD | -16317.073% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -14497.349% |
| Beam Therapeutics Inc. | 173.17 Million USD | 65.018% |
| Neurogene Inc. | 16.25 Million USD | -272.679% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 80.341% |
| AEON Biopharma, Inc. | 278 Thousand USD | -21691.007% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -17983.284% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -56573.621% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | 20.146% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | 0.864% |
| Athira Pharma, Inc. | 1.58 Million USD | -3722.019% |
| Vaccinex, Inc. | 247 Thousand USD | -24425.911% |
| HCW Biologics Inc. | 6.45 Million USD | -838.951% |
| XOMA Corporation | 124.45 Million USD | 51.323% |
| Nektar Therapeutics | 230.4 Million USD | 73.707% |
| Arvinas, Inc. | 3.4 Million USD | -1681.735% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -3612.574% |
| Merus N.V. | 12.16 Million USD | -398.101% |
| Omega Therapeutics, Inc. | 128.42 Million USD | 52.83% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -338.533% |
| Rezolute, Inc. | 2.22 Million USD | -2618.986% |
| Clene Inc. | 32.16 Million USD | -88.362% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -34506.091% |
| BeyondSpring Inc. | 3.99 Million USD | -1416.37% |
| Synlogic, Inc. | 17.27 Million USD | -250.674% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -4559.923% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -172982.857% |
| Peak Bio, Inc. | 10.72 Million USD | -465.007% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -16.671% |
| Krystal Biotech, Inc. | 8.09 Million USD | -648.443% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | 65.778% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -758.424% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -44249.679% |
| MannKind Corporation | 382.37 Million USD | 84.157% |
| Ikena Oncology, Inc. | 10.73 Million USD | -464.155% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -14711.491% |
| Gossamer Bio, Inc. | 212.46 Million USD | 71.487% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -34715.517% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -561.271% |
| Legend Biotech Corporation | 328.67 Million USD | 81.569% |
| Mural Oncology plc | 15 Million USD | -303.618% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -27.734% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -2783.341% |
| Champions Oncology, Inc. | 7.43 Million USD | -715.33% |
| REGENXBIO Inc. | 89.29 Million USD | 32.155% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -6987.775% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -10854.968% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -1018.932% |
| Vaxart, Inc. | 26.51 Million USD | -128.479% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -286.904% |
| Cellectis S.A. | 92.85 Million USD | 34.758% |
| Longeveron Inc. | 2.04 Million USD | -2868.104% |
| Repare Therapeutics Inc. | 3.41 Million USD | -1676.51% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 95.663% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -30.02% |
| Revolution Medicines, Inc. | 87.94 Million USD | 31.116% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -34916.763% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -1432.482% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -19010.095% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -34516.571% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 92.506% |
| Denali Therapeutics Inc. | 52.24 Million USD | -15.961% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -320.528% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -4308.952% |
| Cingulate Inc. | 3.13 Million USD | -1832.283% |
| Passage Bio, Inc. | 26.29 Million USD | -130.391% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -808.912% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -14747.794% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -6676.174% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -194.631% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -4707.857% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -2371.481% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -1839.769% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -7369.667% |
| OmniAb, Inc. | 25.56 Million USD | -136.998% |
| Anew Medical, Inc. | 1.6 Million USD | -3674.393% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -104.777% |
| Lipocine Inc. | 17.16 Thousand USD | -352801.084% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -420.528% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -74.942% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -925.536% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -5.957% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -29741.872% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -1072.875% |
| Ocugen, Inc. | 6.94 Million USD | -772.77% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -328.756% |
| Q32 Bio Inc. | 1.31 Million USD | -4496.282% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -8914.732% |
| Alumis Inc. Common Stock | 32.58 Million USD | -85.939% |
| Equillium, Inc. | 824 Thousand USD | -7251.82% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -567.243% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -20038.894% |
| Galera Therapeutics, Inc. | 152.29 Million USD | 60.224% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -18.462% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -7716.161% |
| Dominari Holdings Inc. | 3.02 Million USD | -1900.627% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -64013.582% |
| vTv Therapeutics Inc. | 529 Thousand USD | -11351.607% |
| Bio-Techne Corporation | 419.53 Million USD | 85.561% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | 15.858% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | 68.704% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -258.71% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -166.141% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -899.983% |
| Nkarta, Inc. | 88.33 Million USD | 31.424% |
| BioCardia, Inc. | 1.31 Million USD | -4506.768% |
| Iterum Therapeutics plc | 19.5 Million USD | -210.518% |